4//SEC Filing
Qian Changgeng 4
Accession 0001181431-09-006990
CIK 0001108205other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 1:34 PM ET
Size
7.7 KB
Accession
0001181431-09-006990
Insider Transaction Report
Form 4
CURIS INCCRIS
Qian Changgeng
VP, Research & Preclinical Dev
Transactions
- Award
Qualified stock option (right to buy)
2009-02-05+20,210→ 20,210 totalExercise: $1.07Exp: 2019-02-05→ Common stock (20,210 underlying) - Award
Non-qualified stock option (right to buy)
2009-02-05+159,790→ 159,790 totalExercise: $1.07Exp: 2019-02-05→ Common stock (159,790 underlying)
Footnotes (1)
- [F1]Options in the aggregate will vest 25% on the one-year anniversary grant date, or February 5, 2010. Remaining options will vest at 6.25% each successive three-month period, with non-qualified options vesting first. Options will be fully vested four years from the grant date.
Documents
Issuer
CURIS INC
CIK 0001108205
Entity typeother
Related Parties
1- filerCIK 0001402196
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 1:34 PM ET
- Size
- 7.7 KB